ROLE OF THYMOSIN BETA-4 IN WOUND HEALING

Release Date:  February 26, 1999

RFP AVAILABLE:  NO. NIH-NIDCR-12-98-2R

P.T.

National Institute of Dental and Craniofacial Research

The National Institute of Dental and Craniofacial Research (NIDCR) has a
requirement for the conduct of a controlled Phase I clinical trial of the
efficacy of thymosin beta-4 on healing of patients with pressure ulcers. The
contractor will be required to recruit a minimum of 40 patients with non-healing,
chronic, pressure ulcers of at least three months.  The objective of the study
is to have thymosin beta-4 tested for its ability to effect wound repair in
venous ulcers, which are the most common form of chronic wounds.

INQUIRIES

Request for Proposals (RFP) NIH-NIDCR-12-98-2R is now available and proposals are
due on or about March 26, 1999.

Requests for the RFP be submitting must be in writing or by FAX to:

Marion L. Blevins
Contracts Management Section
National Institute of Dental and Craniofacial Research
45 Center Drive, Room 4AN-44B, MSC 6402
Bethesda, MD  20892-6402
FAX:  (301) 480-8308


Return to Volume Index

Return to NIH Guide Main Index


Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy


Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.